(Cranbury, NJ — May 4, 2017) - CURE® Magazine, the leading consumer digital and print media enterprise focused entirely on patients with cancer, proudly announces it has been awarded the 2017 Oncology Nursing Society (ONS) Foundation Friend of the Foundation award during the 42nd Annual ONS Annual Congress in Denver, Colorado. In addition, 4,000 oncology nurses were present.
Accepting the award for CURE® Magazine, Michael J. Hennessy Jr. president of Michael J. Hennessy Associates, parent company of CURE® Magazine states, “It is a tremendous honor that CURE® Magazine has been recognized with winning this prestigious award — the Friend of the Foundation. This achievement is a true testament of the talent showed by the whole team and furthering our mission to provide valuable information to patients, caregivers and survivors.”
Headquartered in Pittsburgh, Pennsylvania, Oncology Nursing Society Foundation is the world’s largest professional oncology nursing association. ONS Foundation has provided more than $25 million to fund local and national oncology nursing education, research and leadership opportunities. Additionally, the ONS Annual Congress is being held in conjunction with CURE® Extraordinary Healer® award reception, which will take place at the Hyatt Regency Denver at 6:00pm tonight.
About CURE Media Group
CURE Media Group is the leading resource for cancer updates, research and education. It combines a full suite of media products, including its industry leading website, CUREtoday.com; innovative video programs, such as CURE Connections®; a series of widely attended live events; and CURE® magazine, which reaches over 1 million readers. CURE Media Group is part of the Cranbury, New Jersey-based Michael J. Hennessy Associates, Inc., family of businesses, which includes the acclaimed OncLive® (http://www.onclive.com) platform of resources for the practicing oncologist. For more information, visit http://www.curetoday.com or http://www.mjhassoc.com.
Cure Media Group Press Contacts: Theresa Burek/609-716-7777 ext. 811 tburek@mjhassoc.com
Photograph courtesy of Oncology Nursing Society
Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research
March 4th 2024In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.
Listen